Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in population of patients
4.1.2 Stem cells derived from humans
4.1.3 Rise in research on stem cell
4.2 Restraints
4.2.1 High operating cost
4.2.2 Changes in regulations
4.3 Opportunities
4.3.1 Different procedure to cure diseases.
4.3.2 Advancements in personalised medicine and drugs.
4.4 Challenges
4.4.1.Complexities in the functionality of Stem Cell
Chapter 5 Asia-PacificStem Cell Market - By Treatment
5.1 Syngeneic Stem Cell Therapy
5.2 Allogeneic Stem Cell Therapy
5.3 Autologous Stem Cell Therapy
Chapter 6 Asia-PacificStem Cell Market - By Services
6.1 Cryopreservation
6.2 Stem Cell Banking
6.3 Stem Cell Acquisition and testing
Chapter 7 South America Stem Cell Market - By Application
7.1 Regenerative Medicine
7.1.1 Neurology
7.1.2 Oncology
7.1.3 Cardiology
7.1.4 Others
Drug discovery
7.3 Others
Chapter 8 Asia-PacificStem Cell Market - By Geography
8.1 Introduction
8.2 Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.3. South Korea
8.2.5. Australia & New Zealand
8.2.6. Rest of APAC
Chapter 9 Asia-PacificStem Cell Market - Company Profiles
9.1. Aastrom bioscience
9.2.Cytori Therapeutics, Inc.
9.3.Ocata Therapeutics
9.4.Geron Corporation
9.5. Athersys Inc.,
9.6.StemCells, Inc.
9.7.Cryo-Cell International
9.8.Invitrogen
9.9.Thermo fisher scientific Pvt. Ltd
9.10.Beckton Dickinson and company
9.11.Takara Holdings Inc.
9.12. Stryker Corporation
9.13.GE Healthcare
9.14.Fujifilm Inc.
9.15. BIOTIME, INC.
Chapter 10Asia-PacificStem Cell Market - Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
